相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
Ashwin Singh Parihar et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma
Elena Zamagni et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
18F-Fluciclovine (18F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas
Domenico Albano et al.
ANNALS OF NUCLEAR MEDICINE (2020)
Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT
Qingqing Pan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
[F-18]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0
Cristina Nanni et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Can 18F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?
Christos Sachpekidis et al.
CANCERS (2020)
Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64-labeled daratumumab
Amrita Krishnan et al.
BLOOD ADVANCES (2020)
Comparison of 11C-Choline and 11C-Methionine PET/CT in Multiple Myeloma
Constantin Lapa et al.
CLINICAL NUCLEAR MEDICINE (2019)
Treatment response evaluation with 18F-FDG PET/CT and 18F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation
Christos Sachpekidis et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study
Philippe Moreau et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
Michele Cavo et al.
LANCET ONCOLOGY (2017)
11C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions
Constantin Lapa et al.
THERANOSTICS (2017)
Salicylic Acid Alleviates Aluminum Toxicity in Soybean Roots through Modulation of Reactive Oxygen Species Metabolism
Ning Liu et al.
FRONTIERS IN CHEMISTRY (2017)
A First Report on [18F] FPRGD2 PET/CT Imaging in Multiple Myeloma
Nadia Withofs et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2017)
Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma
Leo Rasche et al.
BLOOD (2017)
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe)
Cristina Nanni et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study
Thibaut Cassou-Mounat et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar et al.
LANCET ONCOLOGY (2016)
C-11-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement
Constantin Lapa et al.
THERANOSTICS (2016)
New criteria for response assessment: role of minimal residual disease in multiple myeloma
Bruno Paiva et al.
BLOOD (2015)
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
Kathrin Philipp-Abbrederis et al.
EMBO MOLECULAR MEDICINE (2015)
Comparison of 11C-4′-thiothymidine, 11C-methionine, and 18F-FDG PET/CT for the detection of active lesions of multiple myeloma
Momoko Okasaki et al.
ANNALS OF NUCLEAR MEDICINE (2015)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
11C-Acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment
Chieh Lin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Comparative evaluation of transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid and L-[methyl-11C]methionine in human glioma cell lines
Masahiro Ono et al.
BRAIN RESEARCH (2013)
Metabolic Tumor Volume Assessed by 18F-FDG PET/CT for the Prediction of Outcome in Patients with Multiple Myeloma
Rosa Fonti et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
Elena Zamagni et al.
BLOOD (2011)
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
Twyla B. Bartel et al.
BLOOD (2009)
Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue Anti-18F-FACBC in humans
Jonathon A. Nye et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Magnetic resonance imaging in multiple myeloma: Diagnostic and clinical implications
Ronald Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Multiple myeloma:: Molecular imaging with 11C-methionine PET/CT -: Initial experience
Anja Dankerl et al.
RADIOLOGY (2007)
分享论文
